DuPont Licenses DxS Multiplex Assay Technology | GenomeWeb

NEW YORK (GenomeWeb News) — DuPont's Qualicon business has licensed DxS' Scorpion multiplex assay platform for use in developing diagnostic tests for the food industry.

Under the agreement, DuPont Qualicon will use the Scorpions technology, a closed-tube platform for PCR analysis for which Manchester, UK-based DxS owns the worldwide intellectual property rights, for use in its development of rapid multiplex assays for detecting microorganisms in food as well as beverage safety and quality.

Financial terms of the agreement were not released.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.